Atherogenic effects of Chlamydia pneumoniae:: Refuting the innocent bystander hypothesis

被引:7
作者
Selzman, CH
Netea, MG
Zimmerman, MA
Weinberg, A
Reznikov, LL
Grover, FL
Dinarello, CA
机构
[1] Univ N Carolina, Sch Med, Div Cardiothorac Surg, Chapel Hill, NC 27599 USA
[2] Univ Colorado, Hlth Sci Ctr, Div Cardiothorac Surg, Denver, CO 80202 USA
[3] Univ Colorado, Hlth Sci Ctr, Div Infect Dis, Denver, CO 80202 USA
关键词
D O I
10.1016/S0022-5223(03)00738-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Serologic evidence of Chlamydia pneumoniae infection and atherosclerosis was first demonstrated in patients with ischemic heart disease in 1988. Subsequently, the organism has been detected in several cardiovascular lesions. Outside of observational reports, few studies mechanistically link vascular infection with C pneumoniae and atherogenesis. To better define its pathophysiologic role, we examined the influence of C pneumoniae infection of human vascular smooth muscle cells on vascular smooth muscle cell proliferation, cell-cycle protein expression, and inflammatory cytokine release. Methods: Human aortic vascular smooth muscle cells were inoculated with C. pneumoniae in culture.. Proliferation was assessed by mitochondrial activity, direct cell counting, and immunohistochemical staining for proliferating cell nuclear antigen. Electromobility gel shift assays probed for the antiproliferative cell-cycle protein p53. Supernatants were assayed for the mitogens interleukin-6 and interleukin-8 by enzyme-linked immunosorbent assay. Results: After C pneumoniae inoculation, vascular smooth muscle cell proliferation increased 2-fold by mitochondrial activity and more than 3-fold by cell numbers. C pneumoniae infection promoted a 3-fold increase in proliferating cell nuclear antigen expression, which was associated with decreased nuclear binding of p53. Compared with control, C. pneumoniae inoculation resulted in a 2.5-fold increase in released interleukin-6 and interleukin-8. In each experiment, the influence of C. pneumoniae was abrogated by concomitant treatment with the macrolide antibiotic azithromycin. Conclusions: C. pneumoniae induced human vascular smooth muscle cell proliferation and proliferating cell nuclear antigen expression, down-regulated p53, and promoted release of prototypical atherogenic cytokines. These in vitro findings indicate that C. pneumoniae is more than an innocent bystander, rather it is a pathophysiologic participant in atherogenesis warranting elimination.
引用
收藏
页码:688 / 693
页数:6
相关论文
共 25 条
[1]   The p53 network [J].
Agarwal, ML ;
Taylor, WR ;
Chernov, MV ;
Chernova, OB ;
Stark, GR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (01) :1-4
[2]   Chlamydia pneumoniae infection of human endothelial cells induces proliferation of smooth muscle cells via an endothelial cell-derived soluble factor(s) [J].
Coombes, BK ;
Mahony, JB .
INFECTION AND IMMUNITY, 1999, 67 (06) :2909-2915
[3]   Chronic infections and coronary heart disease: is there a link? [J].
Danesh, J ;
Collins, R ;
Peto, R .
LANCET, 1997, 350 (9075) :430-436
[4]   Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-κB and induces tissue factor and PAI-1 expression -: A potential link to accelerated arteriosclerosis [J].
Dechend, R ;
Maass, M ;
Gieffers, J ;
Dietz, R ;
Scheidereit, C ;
Leutz, A ;
Gulba, DC .
CIRCULATION, 1999, 100 (13) :1369-1373
[5]   Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells [J].
Gaydos, CA ;
Summersgill, JT ;
Sahney, NN ;
Ramirez, JA ;
Quinn, TC .
INFECTION AND IMMUNITY, 1996, 64 (05) :1614-1620
[6]  
Gupta S, 1997, CIRCULATION, V96, P404
[7]   Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study [J].
Gurfinkel, E ;
Bozovich, G ;
Daroca, A ;
Beck, E ;
Mautner, B .
LANCET, 1997, 350 (9075) :404-407
[8]   In vitro infection of smooth muscle cells by Chlamydia pneumoniae [J].
Knoebel, E ;
Vijayagopal, P ;
Figueroa, JE ;
Martin, DH .
INFECTION AND IMMUNITY, 1997, 65 (02) :503-506
[9]  
KUAKORANTATOLVA.SS, 1996, MICROB PATHOG, V21, P215
[10]   Chronic Chlamydia pneumoniae infection is associated with a serum lipid profile known to be a risk factor for atherosclerosis [J].
Laurila, A ;
Bloigu, A ;
Nayha, S ;
Hassi, J ;
Leinonen, M ;
Saikku, P .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (11) :2910-2913